Wells Fargo’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
NPCM
VCM
Wells Fargo's AGL Position: Q1 2026 in Review
Wells Fargo reduced its Agilon Health (AGL) stake by 66% in Q1 2026, selling an estimated $145K and leaving 4,528 shares worth $35.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5563.
Wells Fargo first reported a position in AGL in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.28M in Q2 2023. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.
- Wells Fargo held 4,528 shares of Agilon Health worth $35.8K as of Q1 2026.
- Wells Fargo sold 8,977 Agilon Health shares in Q1 2026, an estimated $145K.
- Agilon Health made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5563 holding.
- Wells Fargo first reported a position in Agilon Health in Q2 2021 and has held it in 20 quarters since.
- Wells Fargo's Agilon Health position peaked at $1.28M in Q2 2023.
- 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.